Pfizer Inc, the largest research company in the world of drugs, is facing numerous challenges. Key tasks include heavy fighting court with general companies for patent Lipitor, reduced productivity of research and development, as well as changes in the environment of health on a global scale with the growing importance of emerging markets. These problems are in the business environment is characterized by the most multi-level change and uncertainty. The case remains on strategy appointed Chief Executive Officer in the transformation of the giant pharmaceutical organization by changing the business model, strategy and structure to support organic growth, as well as to understand the external features. Is there Pfizer needs more changes, or it is just a matter of time before the new strategy generates results? "Hide
by Michael Rose Source: Richard Ivey School of Business Foundation 26 pages. Publication Date: January 27, 2010. Prod. #: 910M14-PDF-ENG
Related Case Solutions & Analyses:
Coaching for Exceptional Performance Workshop: Associate Wealth Management Steven Leung
Coaching for Exceptional Performance Workshop: Senior Associate Insurance Products James Beringer
El Mawardy Jewelry: Expansion During a Recession
Sam Silvers Decision
The Ultimate Fighting Championship and Cultural Viability
Private Equity at Work: Purchasing Cake Masters
Cartridge World: The Master Franchise Opportunity
Tsingtao Brewery Co. LTD. (B)
Marico Industries Ltd. Central Sales Organization
Wheels Group: Evolution of a Third-Party Logistics Service Provider
